Zoetis Inc. Noncash or Part Noncash Acquisition, Intangible Assets Acquired
Zoetis Inc. (ZTS) reported Noncash or Part Noncash Acquisition, Intangible Assets Acquired of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 · last filed 2017-02-16
- Zoetis Inc. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2015-12-31 was $0.00.
- Zoetis Inc. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2014-12-31 was $0.00.
- Zoetis Inc. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2013-12-31 was $0.00.
- Zoetis Inc. noncash or part noncash acquisition, intangible assets acquired for fiscal 2016 was $0.00.
- Zoetis Inc. noncash or part noncash acquisition, intangible assets acquired for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- Zoetis Inc. noncash or part noncash acquisition, intangible assets acquired for fiscal 2014 was $8.00M.
- Zoetis Inc. noncash or part noncash acquisition, intangible assets acquired for fiscal 2013 was $0.00.
| Period end | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 12 month |
|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-02-16 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $0.00 10-K · filed 2017-02-16 | |
| 2015-09-27 | $0.00 10-Q · filed 2015-11-05 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $8.00M 10-K · filed 2017-02-16 | |
| 2014-09-28 | $8.00M 10-Q · filed 2015-11-05 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $0.00 10-K · filed 2016-02-24 | |
| 2013-09-29 | $0.00 10-Q · filed 2014-11-10 | ||
| 2012-12-31 | $0.00 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |